Which statement best describes EFAD prevention in pediatric PN?

Which statement best describes EFAD prevention in pediatric PN?

• A. Provide approximately 4% of total calories as fat; IVFE 0.5-1.0 g/kg/day will meet this goal
• B. Avoid fat entirely to prevent infection risk
• C. Use only medium-chain triglycerides for all fat
• D. EFAD prevention is unrelated to fat intake

Answer: (A)

Preventing EFAD in pediatric PN hinges on supplying enough essential fatty acids through fat calories. Essential fatty acids like linoleic and alpha-linolenic acids must be provided since the body cannot make them. In PN, this is achieved by including intravenous fat emulsion at a dose that delivers an adequate fat calories share. A practical target is about 4% of total energy as fat, with IV fat emulsion given at roughly 0.5–1.0 g/kg/day. This dosing supplies essential fatty acids while meeting overall caloric needs. Omitting fat entirely would predispose to EFAD, and using only medium-chain triglycerides fails to provide sufficient essential fatty acids. Thus, providing about 4% of calories as fat with appropriate IVFE dosing best prevents EFAD.

Preventing EFAD in pediatric PN hinges on supplying enough essential fatty acids through fat calories. Essential fatty acids like linoleic and alpha-linolenic acids must be provided since the body cannot make them. In PN, this is achieved by including intravenous fat emulsion at a dose that delivers an adequate fat calories share. A practical target is about 4% of total energy as fat, with IV fat emulsion given at roughly 0.5–1.0 g/kg/day. This dosing supplies essential fatty acids while meeting overall caloric needs. Omitting fat entirely would predispose to EFAD, and using only medium-chain triglycerides fails to provide sufficient essential fatty acids. Thus, providing about 4% of calories as fat with appropriate IVFE dosing best prevents EFAD.